Search Results - "Sarles, Harry E."

Refine Results
  1. 1
  2. 2

    Mandated Payor Switching With Infliximab (IFX) Biosimilars: 2058 by Sarles, Harry E., Van Anglen, Lucinda J., Hardin, Thomas C.

    Published in The American journal of gastroenterology (01-10-2018)
    “…A 60-year-old white female with a history of ulcerative pancolitis was hospitalized for a deteriorating clinical course evidenced by diffuse abdominal pain and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease: 703 by Whitney, Annette, Sarles, Harry E., Claudia, Schroeder P., Okoro, Tracy C., Van Anglen, Lucinda J.

    Published in The American journal of gastroenterology (01-10-2018)
    “…Introduction: Vedolizumab (VDZ) is a humanized monoclonal antibody approved for use in adults with inflammatory bowel disease (IBD). There are limited data on…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    839 Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated With Either Infliximab or Vedolizumab by Sarles, Harry E., Hardin, Thomas C., Kuten, Samantha A., Van Anglen, Lucinda J.

    Published in The American journal of gastroenterology (01-10-2019)
    “…INTRODUCTION: Both infliximab (IFX) and vedolizumab (VDZ) are FDA-approved for treatment of inflammatory bowel disease (IBD) in adults. Much of the published…”
    Get full text
    Journal Article
  9. 9

    2516 Use of Ustekinumab in Pediatric Crohn's Disease: A Report of Three Cases by Sarles, Harry E., Whitney, Annette E., Van Anglen, Lucinda J., Kuten, Samantha A., Hardin, Thomas C.

    Published in The American journal of gastroenterology (01-10-2019)
    “…INTRODUCTION: Treatment options for pediatric IBD are limited. Use of non-FDA approved agents to manage difficult pediatric IBD patients (pts) may be…”
    Get full text
    Journal Article
  10. 10

    1147 Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease by Sarles, Harry E., Whitney, Annette E., Kuten, Samantha A., Van Anglen, Lucinda J.

    Published in The American journal of gastroenterology (01-10-2019)
    “…INTRODUCTION: Pediatric patients (pts) with inflammatory bowel disease (IBD) who have failed anti-TNF therapy have limited treatment options. Vedolizumab (VDZ)…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Healthcare Resource Utilization in Inflammatory Bowel Disease Patients: A 2-Year Analysis: 614 by Sarles, Harry E., Van Anglen, Lucinda J., Hardin, Thomas C., Claudia, Schroeder P.

    Published in The American journal of gastroenterology (01-10-2018)
    “…Introduction: Inflammatory bowel disease (IBD) pts can pose challenges for physician management, especially during times of disease flare. While most pts can…”
    Get full text
    Journal Article
  13. 13

    Diarrhea Associated with Mesalamine in a Patient with Chronic Nongranulomatous Enterocolitis by Fine, Kenneth D, Cryer, Byron, Sarles, Harry E

    Published in The New England journal of medicine (26-03-1998)
    “…To the Editor: The use of mesalamine (5-aminosalicylic acid) for the treatment of inflammatory bowel disease seems paradoxical, since structurally similar…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Follicular carcinoma of the thyroid metastatic to the kidney 37 years after resection of the primary tumor by Johnson, M W, Morettin, L B, Sarles, H E, Zaharopoulos, P

    Published in The Journal of urology (01-01-1982)
    “…A case is described of thyroid carcinoma presenting as renal metastases 37 years after initial resection of the primary. Thyroid carcinoma metastatic to the…”
    Get more information
    Journal Article
  16. 16

    Cholera on the Texas Gulf Coast by Kelly, Michael T, Peterson, Johnny W, Sarles, Harry E, Romanko, Michael, Martin, Deborah, Hafkin, Barry

    “…Cholera is being increasingly recognized in the Gulf Coast region. This report describes two cholera cases of classic clinical presentation. Both cases were…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The risk of anticoagulation in hemodialysis patients by Biggers, J A, Remmers, Jr, A R, Glassford, D M, Sarles, H E, Lindley, J D, Fish, J C

    Published in Nephron (2015) (01-01-1977)
    “…The risks of intermittent anticoagulation with heparin for hemodialysis and longterm anticoagulation with warfarin to prevent clotting of arteriovenous shunts…”
    Get more information
    Journal Article
  19. 19
  20. 20